Abstract
Antiplatelet factor 4 (PF4) antibodies have an important role in the most frequent drug-induced immune disorder, heparin-induced thrombocytopenia (HIT). In this issue of Blood, Sachais and coworkers propose a new feature that may explain why only some anti-PF4 antibodies are pathogenic.1 In addition to epitope specificity-determining affinity and a high titer, the ability of antibodies to promote formation of their own target antigens seems to be a key factor for pathogenicity.
Cite
CITATION STYLE
Greinacher, A., Krauel, K., & Jensch, I. (2012, August 2). HIT-antibodies promote their own antigen. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2012-06-430694
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.